Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, announced raising over $100 million in...
Iambic Therapeutics, a clinical-stage biotechnology company developing novel medicines using its AI-driven discovery and development platform, announced that Michael Secora, Ph.D. will be its...